Ribavirin Alternatives Compared
| Ribavirin | Harvoni (ledipasvir / sofosbuvir) | Epclusa (sofosbuvir / velpatasvir) |
|
|---|
| Ribavirin | Harvoni (ledipasvir / sofosbuvir) | Epclusa (sofosbuvir / velpatasvir) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hepatitis C, RSV. Ribavirin may also be used for purposes not listed in this medication guide. |
Prescription only
Harvoni is a combination tablet containing ledipasvir and sofosbuvir. It may be used to treat certain genotypes of the hepatitis C virus in adults and children over the age of three. It is usually... View more |
Prescription only
Epclusa is a combination tablet containing velpatasvir and sofosbuvir. It may be used to treat all six genotypes of the hepatitis C virus in adults and children over the age of three. It is usually... View more |
Related suggestions Popular comparisons
|
|||||||||||||||||||||||
| More about Ribavirin | More about Harvoni (ledipasvir / sofosbuvir) | More about Epclusa (sofosbuvir / velpatasvir) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Ribavirin has an average rating of 4.8 out of 10 from a total of 10 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 50% reported a negative effect. |
Harvoni has an average rating of 8.4 out of 10 from a total of 403 ratings on Drugs.com. 78% of reviewers reported a positive effect, while 11% reported a negative effect. |
Epclusa has an average rating of 7.6 out of 10 from a total of 404 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 12% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Ribavirin side effects |
View all Harvoni side effects |
View all Epclusa side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Ribavirin prices |
View all Harvoni prices |
View all Epclusa prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Rebetol, RibaTab, Virazole |
N/A |
N/A |
||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
960 hours |
47 hours |
27 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 18 drugs are known to interact with Ribavirin:
|
A total of 179 drugs are known to interact with Harvoni:
|
A total of 201 drugs are known to interact with Epclusa:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
June 03, 1998 |
October 10, 2014 |
June 28, 2016 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Arexvy
Arexvy is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Abrysvo
Abrysvo is a vaccine used to prevent respiratory syncytial virus (RSV) lower respiratory tract ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Beyfortus
Beyfortus is used to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in ...
mRESVIA
mRESVIA is a vaccine used to immunize adults aged 60 years and older against lower respiratory ...
Synagis
Synagis is used to prevent lung disease caused by respiratory syncytial virus. Learn about side ...
Rebetol
Rebetol is used with interferon alfa to treat chronic hepatitis C. Learn about side effects ...
Ribasphere
Ribasphere is used in combination with interferon to treat patients with chronic hepatitis C ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.